Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia-Reference-Cited by-同舟云学术

Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia

Published:2017-09-20 Issue:21 Volume:174 Page:3865-3880
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Bombardo Marta¹,Saponara Enrica¹,Malagola Ermanno¹,Chen Rong¹,Seleznik Gitta M¹,Haumaitre Cecile²,Quilichini Evans²,Zabel Anja¹,Reding Theresia¹,Graf Rolf¹³,Sonda Sabrina¹³^ORCID

Affiliation:

1. Swiss Hepato-Pancreato-Biliary Center, Department of Visceral and Transplantation Surgery; University Hospital of Zurich; Zurich Switzerland

2. CNRS, UMR7622, Institut de Biologie Paris-Seine (IBPS); France Sorbonne Universités, UPMC Université Paris 06, UMR7622-IBPS, France INSERM U969; Paris France

3. Center for Integrative Human Physiology (ZIHP); University of Zurich; Zurich Switzerland

Funder

Amélie Waring Foundation

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13984/fullpdf

Reference60 articles.

1. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer;Aghdassi;Gut,2012